6 July 2022 - - Indian clinical stage biotech company Aurigene Discovery Technologies has inked a drug discovery, development and commercialization agreement with US-based biotechnology company EQRx (NASDAQ: EQRX), the company said.
The ...
You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
6 July 2022 - Inmagene Biopharmaceuticals, a developer of novel therapeutics for immunology-related diseases, reported on Wednesday that in partnership with biopharmaceutical company HUTCHMED (China) Limited (Nasdaq:HCM) (AIM:HCM) (HKEX:0013) it has ...
6 July 2022 - Enosi Therapeutics, a Delaware Corporation that is focused on providing therapeutics for cancer and autoimmune diseases, announced on Tuesday that it has collaborated with Hong Kong-based Danuo Science Group.The collaboration is aimed a...
6 July 2022 - Lyra Therapeutics, Inc. (Nasdaq: LYRA), a US-based clinical-stage therapeutics company, announced on Tuesday that it has named Richard Nieman, MD as its new chief medical officer, effective 11 July 2022.Dr Nieman has over 25 years of ex...
6 July 2022 - Japan- based drug development company EditForce, Inc. announced on Tuesday that it has signed a License Agreement with Japan-based Mitsubishi Tanabe Pharma Corporation (MTPC) to research, develop and commercialise potential gene therapy...
5 July 2022 - - The US Food and Drug Administration has lifted the clinical hold placed on the Phase 1/2 clinical trial of VX-880, an investigational stem cell-derived, fully differentiated pancreatic islet cell replacement therapy for people with ty...
5 July 2022 - - US-based biopharmaceutical company Iveric bio, Inc. (NASDAQ: ISEE) and Finland-based technology specialist DelSiTech Ltd have inked an exclusive global license agreement providing Iveric Bio with the right to develop and commerci...